BridgeBio Pharma’s rating of “Buy” has been reaffirmed due to positive results from the ATTRibute-CM study.
Read More: https://www.tipranks.com/news/blurbs/buy-rating-affirmed-on-bridgebio-pharma-amid-promising-attribute-cm-study-results?utm_source=alphanewsstream.com&utm_medium=referral